SCHEMBL4024602

SCHEMBL4024602

CCOc1ccccc1-c1ccc2nc(-c3cccc(F)c3)cc(NC)c2c1

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 18/20 0.50
DHFR P00374 1/20 0.44
CYP2C9 P11712 2/20 0.43
NR3C1 P04150 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026246 0.89 LMNA (0.50) CYP2C9
SCHEMBL4028870 0.83 CYP1A2 (0.47) CYP2C9
SCHEMBL4031373 0.82 ABCG2 (0.52)
SCHEMBL4026944 0.82 CLK4 (0.47) CYP2C9
SCHEMBL4025363 0.81 ABCG2 (0.48)
SCHEMBL4025241 0.80 ACP1 (0.44)
SCHEMBL4023370 0.76 NT5E (0.49) CYP2C9
SCHEMBL8269935 0.76 PDE10A (0.62) PDE10ACYP2C9
SCHEMBL4816411 0.75 ABCG2 (0.52)
SCHEMBL4021555 0.75 NT5E (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339690-B1 N-TYPE CALCIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2009-01-21 EP disclosed